The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Subject File, 1902-2012 (continued)
BOX II:193 Submission management and review tracking, 1995
BOX II:193 Summers, William K., 1987-1989, 1997-1999, undated
BOX II:193 Supplements, memoranda by Kelsey, 1968
BOX II:194 Suprofen, 1987
BOX II:194 Tamoxifen, report, 1997
BOX II:194 Taussig, Helen B., 1977, 1988, 1994, 2001, undated
BOX II:194 Teplick, Steven K., hearing at U.S. Food and Drug Administration, 1993-1999
BOX II:194 Teratology
BOX II:194 General, 1946, 1960-1962, 1968-1997, undated
(2 folders)
BOX II:194 Screening procedures
BOX II:194 1962-1969
(3 folders)
BOX II:195 circa 1960s
BOX II:195 1970-1995, undated
(9 folders)
BOX II:195 Teratology Society, 1961, 1974, 1984-1988, 1998, 2011, undated
BOX II:196 Tetracyclines/sulfonamides, 1961-1979, undated
BOX II:196 Thalidomide
BOX II:196 Archer, John D., 1960-1979, 1986, 1996-1998, undated
(2 folders)
BOX II:196 Bell, Peter D., “The Thalidomide Case,” 1963, 1995
BOX II:196 Broadsides, “Drug Detective, Frances O. Kelsey, M.D.,” circa 1963 See also Oversize
BOX II:196 Burkholz, Herbert, “Giving Thalidomide a Second Chance,” 1997
BOX II:196 Chick studies, 1962-1969
BOX II:196 CIBA Pharmaceutical Co., 1962, undated
BOX II:196 Cost recovery for thalidomide for sponsor-investigator investigational new drugs, 1996, undated
BOX II:196 Deformities, no evidence of, 1962-1963
BOX II:196 Drug deformities
BOX II:196 Foundation for Medical Research Perinatal Study, Philadelphia, Pa., 1962-1966
BOX II:196 Northrup, Harriett E., 1962
BOX II:197 Epstein, Beryl, and Samuel Epstein, Who Says You Can’t?, 1968
BOX II:197 Exhibits, 1956-1961
BOX II:197 FDA Consumer Memo andFDA Fact Sheet, 1968, 1974
BOX II:197 FDA Dermatological and Ophthalmic Drugs Advisory Committee, 1996-1997
BOX II:197 FDA Thalidomide Working Group
BOX II:197 1961, 1988-1998
(7 folders)
BOX II:198 1999-2001
(4 folders)
BOX II:198 Undated and fragments
BOX II:198 FDA/National Institutes of Health Workshop, “Thalidomide: Potential Benefits and Risks,” 1997
(1 folder)
BOX II:199 (2 folders)
BOX II:199 General
BOX II:199 1960-1979
(6 folders)
BOX II:200 1980-2002, undated
(7 folders)
BOX II:200 Inspection report for SKG #5627, 1962
BOX II:201 Investigation of Trent Busby, 1961-1962
BOX II:201 Isomers and others, 1961-1963, 1970, 1979-1990, undated
(2 folders)
BOX II:201 Kevadon
BOX II:201 Memoranda, 1960-1962
(3 folders)
BOX II:201 Microfiche of documents from unapproved new drug applications 12611 and 12711 (thalidomide) obtained through Freedom of Information Act request of John Carey, 1978
Microfiche shelf no. 22,656
BOX II:201 Telephone calls, 1962-1963
(2 folders)
BOX II:201 Legal cases
BOX II:201 Diamond, Thomas David, 1962, 1969
BOX II:201 Grünenthal GmbH
BOX II:201 Brochure material, William S. Merrell Co., circa 1961
BOX II:202 Correspondence
BOX II:202 Distillers Co. (Biochemicals), circa 1959-1962
BOX II:202 National Drug Co., 1961-1962
(2 folders)
BOX II:202 William S. Merrell Co., 1961-1962
(3 folders)
BOX II:202 Kelsey memorandum, 1994
BOX II:202 Marshall, Alan David, 1962
BOX II:202 McCarrick v. Richardson-Merrell, includes testimony of Kelsey, 1971
BOX II:202 McKenna v. United States, 1995-1996
BOX II:203 Rowe, Lynette Suzanne, 2012
BOX II:203 United States v. John Doe, 1962
BOX II:203 Material received through Freedom of Information Act request of Burton L. Appleton, 1960-1961, 1995
BOX II:203 Names marketed under, undated
BOX II:203 Peripheral neuritis, 1961-1973, 1984, 1993-1997
BOX II:203 Popular and semipopular articles, 1963
BOX II:203 Press coverage and Kelsey, 1962
BOX II:203 Numbered
BOX II:203 Vols. 3-9
(5 folders)
BOX II:204 Vols. 11-14
(3 folders)
BOX II:204 Unnumbered
BOX II:204 Vols. A-D
(4 folders)
BOX II:205 Vols. E-M
(9 folders)
BOX II:206 Smith, Kline & French Laboratories, Philadelphia, Pa., 1962, 1995
(2 folders)
BOX II:206 Survey of city health workers, 1962
BOX II:206 Taussig, Helen B. See Container II:194, same heading
BOX II:206 Therakos, Inc. See Container II:186, Oxsoralen
BOX II:206 Third-party certification, 1994-2000
(3 folders)
BOX II:206 Third-party notification, 1979-1984, undated
(2 folders)
BOX II:206 Thyroid: diseases, iodine, iodine 131, and thyroxine, 1960-1972, 1978-1988, 1998-2001, undated
BOX II:206 Toxic shock syndrome, 1980-1984
BOX II:206 Toxicology
BOX II:206 1944, 1952-1969
BOX II:207 1970, 1977-1982, 1993-1998, undated
BOX II:207 Tranquilizers
BOX II:207 General, 1962-1969, 1980, 1991, 1998, undated
BOX II:207 Milkovitch, Lucille, 1972-1974, undated
BOX II:207 Stelazine investigation, 1953-1962, undated
(2 folders)
BOX II:207 Triancinalone, 1962-1968
BOX II:207 Triflocin, 1975, 1996, undated
BOX II:207 Triparanol (MER-29), 1962-1966, 2001
BOX II:208 Tuchmann-Duplessis, Herbert, articles, 1963-1964
BOX II:208 University Group Diabetes Program, 1976-1979, 1996-1999
BOX II:208 Urokinase, 1972-1974
BOX II:208 “Use of Drugs for Unapproved Indications: Your Legal Responsibility,” 1972, 1987
BOX II:208 Useless drugs lists, circa 1960-circa 1962
BOX II:208 Vasodilator, 1962, 1972, 1997
BOX II:208 Versed, 1989, undated
BOX II:208 Vicks investigation, 1975
BOX II:208 Vidarabine, 1975-1979
BOX II:208 Viral infections including German measles, 1941, 1961-1974, 1980-1993, undated
(2 folders)
BOX II:208 Virazole, 1978-1988, 1996-2000, undated
Next Page »

Contents List